In this special after-show episode, we continue the conversation on protecting patients from counterfeit medicines with Blair Korman, Senior Director of Digital Identification & Traceability at Johnson & Johnson. 

Building on Episode 7, we explore the real-world challenges of implementing serialisation in countries without traceability laws, the role GS1 standards play in making it possible, and the impact this initiative is already having on the ground.